INDICATORS ON COBICISTAT YOU SHOULD KNOW

Hepatic impairment No dose adjustment is needed in sufferers with delicate or reasonable (Child-Pugh A or B) hepatic impairment (see segment 5.2). Exposure to midostaurin and its Lively metabolite CGP62221 is significantly lessen in patients with serious hepatic impairment than that in clients with usual hepatic purpose (see part five.has a protrac